Keros Therapeutics, Inc. (KROS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Keros Therapeutics Inc KROS
$10.67
▲ +2.50%
(+$0.26)
Open
$10.66
Prev Close
$10.41
Day Range
$10.43 – $10.93
52W Range
$9.69 – $22.55
Market Cap
$210.78M
P/E (TTM)
2.42
Beta
0.99
EPS (TTM)
$-3.01
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-04-08 |
| Shares Out. | 19,790,000 |
| Website | kerostx.com/ ↗ |
| Phone | 16173146297 |
Keros Therapeutics Inc is a publicly traded company under the ticker symbol KROS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-06-01)